Sure Pulse Medical

Home
United Kingdom
Nottingham
Sure Pulse Medical

Rapid wireless monitoring for newborns. www.surepulsemedical.com

07/01/2026

“The SurePulse device has potential to be a significant advancement in the way neonatal patients are monitored in a variety of post-delivery circumstances .”
— Jennifer Peterson et al., 2024, Frontiers in Pediatrics

🔍 Explore the full study → https://buff.ly/4bfBRif

Image: Comparison of traditional monitoring (left) vs. SurePulse VS Cap (right)
Image credit: Frontiers in Pediatrics

05/01/2026

How much oxygen should we start with when resuscitating extremely preterm infants?

A major new randomized clinical trial published in JAMA provides important clarity.

The TORPIDO 30/60 Trial studied 1,469 infants born at 23–28 weeks’ gestation across 31 hospitals in 6 countries, comparing initial resuscitation with FiO₂ 0.6 vs FiO₂ 0.3.

Key findings:

󠁯•󠁏󠁏 No difference in risk of death or brain injury at 36 weeks’ corrected gestational age
(46.9% vs 47.8%)
󠁯•󠁏󠁏 Similar need for escalation to FiO₂ 1.0 in both groups
󠁯•󠁏󠁏 Outcomes were consistent across this large, international cohort

What this means:
Starting resuscitation with a higher oxygen concentration (FiO₂ 0.6) did not improve outcomes compared with FiO₂ 0.3, reinforcing the importance of careful oxygen titration rather than higher initial exposure.

📄 Read the full study:
https://doi.org/10.1001/jama.2025.23327

31/12/2025

2025 has been a pivotal year for SurePulse.

This year, our team reached several major milestones, including successfully delivering two significant grant-funded projects which involved running clinical investigations of our next-generation neonatal monitoring devices with newborn babies.

We also:

⬩ Completed a neonatal simulation study in collaboration with Glasgow Children’s Hospital, strengthening the evidence behind how our technology performs in real-world resuscitation scenarios

⬩ Secured further funding to advance development of our new user interface and display, shaped by direct clinician feedback (with thanks to Medilink and Nottingham City Shared Prosperity Fund (SPF) 2023–2025)

⬩ Won a national award alongside the University of Nottingham for 'Collaboration Between Academia and Industry', bringing engineers, clinicians, researchers and families together around one shared goal: better monitoring in the most critical moments of life.

We’re incredibly proud of what’s been achieved in 2025 and deeply grateful to our team, clinical partners, funders and the families who made this work possible.

Onwards to 2026, with even more innovation ahead.

29/12/2025

Optimal care for newborn babies in the first few ‘golden’ minutes after birth is critical to prevent significant illness or even death. A rise in heart rate is the most important indicator of effective ventilation and response to resuscitation interventions (Aziz et al, 2020), however current monitoring methods fall short, risking over treatment . The SurePulse VS Cap comprises an optical sensor integrated into a thermo-protective single-use cap which has been designed to provide clinical teams with accurate, reliable, and timely heart rate information in the critical moments after birth. Found out more: https://buff.ly/l7TM0Dy

22/12/2025

The International Liaison Committee on Resuscitation (ILCOR) recommends covering a newborn’s head with a cap in their latest guidance.
After reviewing research, ILCOR found that not using a cap on a newborn's head at birth increases the risk of hypothermia upon admission to the NICU. This simple step, adding a cap, can help maintain a baby’s normal temperature, which is crucial for reducing adverse outcomes.

Innovations like the SurePulse VS take this a step further, combining thermal protection with cutting-edge heart rate monitoring, giving clinical teams accurate data during those critical first moments of life. Read more about the recommendation here: https://buff.ly/3BcAOlr

15/12/2025

This Wednesday, we’ll be working with the West of Scotland Innovation Hub at the Royal Hospital for Children, Glasgow, working with clinical teams to run a simulation study using our new multi-parameter neonatal monitoring device.

Collaborating in clinical environments helps ensure our technology truly supports patients, parents, and frontline care teams.

We’re incredibly grateful to Medilink and the Nottingham City Council Shared Prosperity Fund (SPF) 2023–2025 for their support of this project.

11/12/2025

A multi-cohort analysis led by Yanlin Zhou et al. (Warwick, UK), presented at jENS 2025, highlights the long-term socioeconomic impact of being born very preterm (VPT) or with very low birth weight (VLBW).

The analysis shows that although many VPT/VLBW individuals transition into adulthood similarly to term-born peers, they continue to face lower educational attainment, reduced employment participation, and increased reliance on social benefits.

The strongest predictor of these challenges? Neurosensory Impairment (NSI)—increasing the likelihood of social benefit use nearly sevenfold. But even those without NSI remain at elevated risk.

The takeaway: Early interventions in the NICU that reduce medical complications, along with enhanced educational support throughout childhood, may help mitigate long-term socioeconomic disparities for individuals born VPT/VLBW.

Read more here: https://www.surepulsemedical.com/socioeconomic-outcomes-in-very-preterm-and-very-low-birth-weight-adults

08/12/2025

Dr Neil Patel, Consultant Neonatologist at Glasgow Children’s Hospital discusses the advantages of using wireless systems to monitor babies in neonatal intensive care units.

To find out more about SurePulse's wireless monitoring for newborns, visit our website https://buff.ly/45OVJ8Z

03/12/2025

New insights from the COSGOD III trial explore whether optimal cord clamping improves early brain oxygenation in preterm infants. The analysis of 572 babies found no significant differences in cerebral oxygenation across different clamping times, although delayed clamping still offers other well-established benefits.

These findings are highly relevant to SurePulse as we develop a wireless, multi-parameter monitoring device designed for use even during delayed cord clamping, giving Clinicians rapid, accurate vital signs to support early decision making.

Read the full article here 🔗
https://www.surepulsemedical.com/does-delayed-cord-clamping-improve-early-brain-oxygenation-in-preterm-infants-new-insights-from-the-cosgod-iii-trial

01/12/2025

Looking back to earlier this summer when our CEO James Carpenter appeared on the Lifeblood podcast to discuss how his journey through academia led to building and leading a MedTech company.

In this episode, Giovanni and James dive into:
🔹 The neonatal care market
🔹 Signal processing, algorithms, and AI
🔹 Grant writing & raising capital from angel investors
🔹 Commercializing a medical device
🔹 UK football
…and more.

🎧 Listen here:

26/11/2025

The INTACT-2 feasibility study, led by Elisabeth Saether and colleagues in Ålesund, Norway, explores an innovative approach to preserving the benefits of delayed cord clamping (DCC) in scenarios where it is often difficult to achieve, particularly during caesarean deliveries.

By delivering the placenta before cord clamping, continued placental transfusion can be maintained even outside the uterus. When needed, the newborn can be moved to a resuscitaire while still attached to the placenta, enabling stabilisation with an intact cord and supporting a smoother physiological transition.

The findings show that extra-uterine placental transfusion with intact-cord stabilisation is both feasible and clinically promising, offering a practical solution when standard DCC cannot be performed during caesarean birth.

Read the full article to learn more:
https://buff.ly/JPR4xFh

24/11/2025

Traditional ECG heart rate monitoring isn’t designed for newborns.

❌ Slow to attach & prone to dislodgement (Mizumoto, 2012)
❌ Risk of damaging delicate newborn skin (Anton, 2019)
❌ Wires interfere with crucial delivery room cuddles & kangaroo care (Bonner, 2017)

At SurePulse, we’re transforming neonatal monitoring with solutions designed to make it safer, faster, and more family-friendly. Discover more about these challenges: https://buff.ly/ZDf0ewU

Address

Medicity, D6 Thane Road
Nottingham
NG906BH

Website

http://www.surepulsemedical.com/

Alerts

Be the first to know and let us send you an email when Sure Pulse Medical posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Want your practice to be the top-listed Clinic in Nottingham?